Vanguard Portfolio Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766M Buy
21,641,339
+1,802,641
+9% +$53.3M 0.03% 530
2026
Q1
$550M Buy
+19,838,698
New +$510M 0.03% 625

Other funds holding ROIV

Vanguard Portfolio Management's ROIV Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Roivant Sciences (ROIV) stake by 9.1% in Q2 2026, buying an estimated $53.3M and bringing the position to 21,641,339 shares worth $766M. The position accounts for 0.03% of the portfolio, ranked #530.

Vanguard Portfolio Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vanguard Portfolio Management held 21,641,339 shares of Roivant Sciences worth $766M as of Q2 2026.
  • Vanguard Portfolio Management bought 1,802,641 Roivant Sciences shares in Q2 2026, an estimated $53.3M.
  • Roivant Sciences made up 0.03% of Vanguard Portfolio Management's portfolio in Q2 2026, its #530 holding.
  • Vanguard Portfolio Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.